Literature DB >> 6360903

Legionella pneumophila-induced blastogenesis of murine lymphoid cells in vitro.

H Friedman, R Widen, T Klein, L Searls, K Cabrian.   

Abstract

Legionella pneumophilia antigen preparations, either killed whole cell vaccine, a soluble sonic extract, or a purified large-molecular-weight somatic antigen, stimulated blastogenic responses by splenocytes from both normal and Legionella-sensitized mice. Graded amounts of the bacterial preparations, when added to cultures of normal spleen cells, resulted in increased uptake of thymidine into cellular DNA, indicating that the preparations were mitogenic for normal mouse splenocytes. Spleen cells from mice injected with graded numbers of living bacteria showed blastogenic responsiveness to Legionella preparations generally at a higher level than spleen cells from normal animals. The heightened blastogenic response was mainly evident with spleen cells obtained from mice injected with living bacteria 2 to 3 weeks earlier. Splenocytes from mice infected with legionella less than 1 to 2 weeks or for more than 4 to 5 weeks responded generally similar to those obtained from uninjected mice, indicating that sensitization with living organisms had a relatively short duration. Spleen cell suspensions responding to the L. pneumophila antigens appeared to be mainly B-lymphocytes since cell suspensions from athymic nude mice deficient in T-cells responded as well as cells from conventional mice. Furthermore, passage of splenocytes over nylon wool columns to obtain B-cell-enriched preparations resulted in cell populations capable of responding to Legionella antigen. The cell fractions rich in T-cells were much less capable of responding to the Legionella antigens. In addition, treatment of spleen cell populations with antitheta serum plus complement failed to inhibit the blastogenic response, whereas the same spleen cell preparations treated with anti-mouse immunoglobulin serum plus complement markedly diminished blastogenic responsiveness, again consistent with the likelihood that B-lymphocytes were the major cell class responding to the Legionella preparations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360903      PMCID: PMC263428          DOI: 10.1128/iai.43.1.314-319.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  In vitro interaction between normal cynolmolgus monkey alveolar macrophages and Legionnaires disease bacteria.

Authors:  R A Kishimoto; M D Kastello; J D White; F G Shirey; V G McGann; E W Larson; K W Hedlund
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  The pathology of Legionnaires' disease. Fourteen fatal cases from the 1977 outbreak in Vermont.

Authors:  W C Winn; F L Glavin; D P Perl; J L Keller; T L Andres; T M Brown; C M Coffin; J E Sensecqua; L N Roman; J E Craighead
Journal:  Arch Pathol Lab Med       Date:  1978-07       Impact factor: 5.534

4.  Upper limit of normal titer for detection of antibodies to Legionella pneumophila by the microagglutination test.

Authors:  G C Klein; W L Jones; J C Feeley
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

5.  Development of a chemically defined liquid medium for growth of Legionella pneumophila.

Authors:  L Pine; J R George; M W Reeves; W K Harrell
Journal:  J Clin Microbiol       Date:  1979-05       Impact factor: 5.948

6.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

7.  Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

8.  A high molecular weight antigen in Legionnaires' disease bacterium: isolation and partial characterization.

Authors:  W Johnson; J A Elliott; C M Helms; E D Renner
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

9.  Immunologic protection against the Legionnaires' disease bacterium in the AKR/J mouse.

Authors:  K W Hedlund; V G McGann; D S Copeland; S F Little; R G Allen
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

Review 10.  Legionnaires' disease.

Authors:  R D Meyer; S M Finegold
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

View more
  16 in total

1.  Infection of macrophages with Legionella pneumophila induces phosphorylation of a 76-kilodalton protein.

Authors:  Y Yamamoto; T W Klein; H Shinomiya; M Nakano; H Friedman
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Differential effects of virulent versus avirulent Legionella pneumophila on chemokine gene expression in murine alveolar macrophages determined by cDNA expression array technique.

Authors:  N Nakachi; K Matsunaga; T W Klein; H Friedman; Y Yamamoto
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Induction of cytokine granulocyte-macrophage colony-stimulating factor and chemokine macrophage inflammatory protein 2 mRNAs in macrophages by Legionella pneumophila or Salmonella typhimurium attachment requires different ligand-receptor systems.

Authors:  Y Yamamoto; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity.

Authors:  R H Widen; C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Legionella pneumophila suppresses macrophage interleukin-12 production by activating the p42/44 mitogen-activated protein kinase cascade.

Authors:  Kazuto Matsunaga; Hiroyuki Yamaguchi; Thomas W Klein; Herman Friedman; Yoshimasa Yamamoto
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  Epigallocatechin gallate, a potential immunomodulatory agent of tea components, diminishes cigarette smoke condensate-induced suppression of anti-Legionella pneumophila activity and cytokine responses of alveolar macrophages.

Authors:  Kazuto Matsunaga; Thomas W Klein; Herman Friedman; Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

7.  Differential morphologic and metabolic alterations in permissive versus nonpermissive murine macrophages infected with Legionella pneumophila.

Authors:  Y Yamamoto; T W Klein; K Brown; H Friedman
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

8.  Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice.

Authors:  Y Yamamoto; T W Klein; C A Newton; R Widen; H Friedman
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

9.  Cyclic AMP inhibition of lipopolysaccharide-induced restriction of Legionella pneumophila growth in macrophage cultures.

Authors:  K Egawa; T W Klein; Y Yamamoto; C A Newton; H Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

10.  Lymphoid cell blastogenesis as an in vitro indicator of cellular immunity to Legionella pneumophila antigens.

Authors:  F Friedman; R Widen; T Klein; H Friedman
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.